iodixanol has been researched along with Cancer of Pancreas in 5 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Frehtman, V | 1 |
Wohlfarth, D | 1 |
Müller, M | 1 |
Krebs, O | 1 |
Leuchs, B | 1 |
Kawamoto, S | 1 |
Fuld, MK | 1 |
Laheru, D | 1 |
Huang, P | 1 |
Fishman, EK | 1 |
Loizou, L | 1 |
Albiin, N | 1 |
Leidner, B | 1 |
Axelsson, E | 1 |
Fischer, MA | 1 |
Grigoriadis, A | 1 |
Del Chiaro, M | 1 |
Segersvärd, R | 1 |
Verbeke, C | 1 |
Sundin, A | 1 |
Kartalis, N | 1 |
Cattaneo, GM | 2 |
Passoni, P | 2 |
Sangalli, G | 1 |
Slim, N | 1 |
Longobardi, B | 1 |
Mancosu, P | 2 |
Bettinardi, V | 2 |
Di Muzio, N | 2 |
Calandrino, R | 1 |
Gusmini, S | 1 |
Cappio, S | 1 |
Gilardi, MC | 1 |
Reni, M | 1 |
Del Maschio, A | 1 |
Fazio, F | 1 |
1 review available for iodixanol and Cancer of Pancreas
Article | Year |
---|---|
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Fe | 2018 |
1 trial available for iodixanol and Cancer of Pancreas
Article | Year |
---|---|
Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.
Topics: Aged; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Humans; Iopamidol; Male; Multidetector C | 2016 |
3 other studies available for iodixanol and Cancer of Pancreas
Article | Year |
---|---|
Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application.
Topics: Glioblastoma; H-1 parvovirus; Humans; Oncolytic Virotherapy; Oncolytic Viruses; Pancreatic Neoplasms | 2023 |
Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Four-Dimension | 2010 |
Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.
Topics: Carcinoma, Pancreatic Ductal; Contrast Media; Humans; Pancreas; Pancreatic Neoplasms; Radiographic I | 2008 |